These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31467903)

  • 1. Analysis of the
    Mi XX; Yan J; Ma XJ; Zhu GL; Gao YD; Yang WJ; Kong XW; Chen GY; Shi JP; Gong L
    Biomed Res Int; 2019; 2019():6272174. PubMed ID: 31467903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of UGT1A1 genotype-phenotype correlation in Chinese patients with gilbert and crigler-Najjar II syndrome.
    Wu L; Li Z; Song Y; Li Y; Zhang W; Zhong X; Wang X; Huang J; Ou X
    Eur J Med Genet; 2024 Oct; 71():104962. PubMed ID: 39069255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome.
    Maruo Y; Nakahara S; Yanagi T; Nomura A; Mimura Y; Matsui K; Sato H; Takeuchi Y
    J Gastroenterol Hepatol; 2016 Feb; 31(2):403-8. PubMed ID: 26250421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of UGT1A1 variations to chemotherapy-induced unconjugated hyperbilirubinemia in pediatric leukemia patients.
    Nomura A; Maruo Y; Taga T; Takeuchi Y
    Pediatr Res; 2016 Aug; 80(2):252-7. PubMed ID: 27057738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UGT1A1 genotypes and unconjugated hyperbilirubinemia phenotypes in post-neonatal Chinese children: A retrospective analysis and quantitative correlation.
    Abuduxikuer K; Fang LJ; Li LT; Gong JY; Wang JS
    Medicine (Baltimore); 2018 Dec; 97(49):e13576. PubMed ID: 30544479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.
    Chen Z; Su D; Ai L; Jiang X; Wu C; Xu Q; Wang X; Fan Z
    Gene; 2014 Nov; 552(1):32-8. PubMed ID: 25200497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UGT1A1 genetic analysis as a diagnostic aid for individuals with unconjugated hyperbilirubinemia.
    Skierka JM; Kotzer KE; Lagerstedt SA; O'Kane DJ; Baudhuin LM
    J Pediatr; 2013 Jun; 162(6):1146-52, 1152.e1-2. PubMed ID: 23290513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional polymorphism in UGT1A1 related to hyperbilirubinemia is associated with a decreased risk for Crohn's disease.
    de Vries HS; Te Morsche RH; Jenniskens K; Peters WH; de Jong DJ
    J Crohns Colitis; 2012 Jun; 6(5):597-602. PubMed ID: 22398043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical UGT1A1 Genetic Analysis in Pediatric Patients: Experience of a Reference Laboratory.
    Moyer AM; Skierka JM; Kotzer KE; Kluge ML; Black JL; Baudhuin LM
    Mol Diagn Ther; 2017 Jun; 21(3):327-335. PubMed ID: 28213806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of UGT1A1 promoter polymorphism, α-thalassemia and β
    Batista JVGF; Arcanjo GS; Batista THC; Sobreira MJ; Santana RM; Domingos IF; Hatzlhofer BL; Falcão DA; Pereira-Martins DA; Oliveira JM; Araujo AS; Laranjeira LPM; Medeiros FS; Albuquerque FP; Albuquerque DM; Santos MN; Hazin MF; Dos Anjos AC; Costa FF; Araujo AS; Lucena-Araujo AR; Bezerra MA
    Ann Hematol; 2021 Apr; 100(4):903-911. PubMed ID: 33523291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab.
    Lee JS; Wang J; Martin M; Germer S; Kenwright A; Benayed R; Spleiss O; Platt A; Pilson R; Hemmings A; Weinblatt ME; Kaplowitz N; Krasnow J
    Pharmacogenet Genomics; 2011 Jul; 21(7):365-74. PubMed ID: 21412181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Gilbert's-like" syndrome as part of a spectrum of persistent unconjugated hyperbilirubinemia in post-chronic hepatitis patients.
    Ye J; Cui L; Zhou Y; Huang Y; Banafa O; Hou X; Ding Z; Lin R
    Sci Rep; 2018 Jan; 8(1):2008. PubMed ID: 29386646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of UGT1A1 variants in Pakistani children affected with inherited unconjugated hyperbilirubinemias.
    Zubaida B; Cheema HA; Hashmi MA; Naeem M
    Clin Biochem; 2019 Jul; 69():30-35. PubMed ID: 31145902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of uridine diphosphate glucuronosyl transferase 1A1 gene mutations in neonates with unconjugated hyperbilirubinemia.
    Guo XH; Sun YF; Cui M; Wang JB; Han SZ; Miao J
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound heterozygous UGT1A1*28 and UGT1A1*6 or single homozygous UGT1A1*28 are major genotypes associated with Gilbert's syndrome in Chinese Han people.
    Zhang M; Wang H; Huang Y; Xu X; Liu W; Ning Q; Chen T; Qi J
    Gene; 2021 May; 781():145526. PubMed ID: 33631237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of co-inherited Gilbert syndrome on hyperbilirubinemia in Indian beta thalassemia patients.
    Dabke PS; Colah RB; Ghosh KK; Nadkarni AH
    Hematology; 2014 Oct; 19(7):388-92. PubMed ID: 24620945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects.
    Rodrigues C; Vieira E; Santos R; de Carvalho J; Santos-Silva A; Costa E; Bronze-da-Rocha E
    Blood Cells Mol Dis; 2012 Mar; 48(3):166-72. PubMed ID: 22325916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms.
    Mori S; Terada K; Ueki Y
    Mod Rheumatol; 2012 Aug; 22(4):515-23. PubMed ID: 21993917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of the UGT1A1*28 Polymorphism in a Romanian Cohort of Gilbert Syndrome Individuals.
    Radoi VE; Ursu RI; Poenaru E; Arsene C; Bohiltea CL; Bohiltea R
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):25-28. PubMed ID: 28338110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia.
    Peer CJ; Sissung TM; Kim A; Jain L; Woo S; Gardner ER; Kirkland CT; Troutman SM; English BC; Richardson ED; Federspiel J; Venzon D; Dahut W; Kohn E; Kummar S; Yarchoan R; Giaccone G; Widemann B; Figg WD
    Clin Cancer Res; 2012 Apr; 18(7):2099-107. PubMed ID: 22307138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.